VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10009597 | HBV | ENSG00000064989.13 | protein_coding | CALCRL | No | No | 10203 | Q16602 |
TVIS10011300 | HBV | ENSG00000064989.13 | protein_coding | CALCRL | No | No | 10203 | Q16602 |
TVIS10041989 | HBV | ENSG00000064989.13 | protein_coding | CALCRL | No | No | 10203 | Q16602 |
TVIS30051950 | HIV | ENSG00000064989.13 | protein_coding | CALCRL | No | No | 10203 | Q16602 |
TVIS20000113 | HPV | ENSG00000064989.13 | protein_coding | CALCRL | No | No | 10203 | Q16602 |
TVIS20001686 | HPV | ENSG00000064989.13 | protein_coding | CALCRL | No | No | 10203 | Q16602 |
TVIS44048722 | HTLV-1 | ENSG00000064989.13 | protein_coding | CALCRL | No | No | 10203 | Q16602 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | CALCRL |
---|---|
DrugBank ID | DB15328 |
Drug Name | Ubrogepant |
Target ID | BE0009009 |
UniProt ID | Q16602 |
Regulation Type | antagonist |
PubMed IDs | 33749826 |
Citations | Blumenfeld AM, Goadsby PJ, Dodick DW, Hutchinson S, Liu C, Finnegan M, Trugman JM, Szegedi A: Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis. Headache. 2021 Mar;61(3):422-429. doi: 10.1111/head.14089. Epub 2021 Mar 22. |
Groups | Approved; Investigational |
Direct Classification | |
SMILES | C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1 |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL2364638 |